ClinicalTrials.Veeva

Find clinical trials for Asthma in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Chronic Obstructive Pulmonary Disease
Obstructive Lung Diseases
Rhinitis
Respiration Disorders
Respiratory Tract Diseases

Asthma trials near London, England, GBR:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations a...

Enrolling
Asthma
Drug: Benralizumab
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

London, United Kingdom and 80 other locations

This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...

Enrolling
Asthma
Asthma; Eosinophilic
Drug: Placebo
Drug: Dexpramipexole Dihydrochloride

Phase 3

Areteia Therapeutics

Enfield Town, United Kingdom and 125 other locations

This is a study designed to evaluate efficacy and safety of Tezepelumab in reducing oral corticosteroid use in adult patients with severe asthma...

Active, not recruiting
Asthma
Biological: Tezepelumab

Phase 3

AstraZeneca
AstraZeneca

London, United Kingdom and 76 other locations

is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...

Enrolling
Asthma
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

High Wycombe, United Kingdom and 45 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Enrolling
Asthma Attack
Asthma; Eosinophilic
Drug: Placebo
Drug: Dexpramipexole Dihydrochloride

Phase 3

Areteia Therapeutics

Enfield Town, United Kingdom and 117 other locations

12 years old with moderate to severe asthma....

Enrolling
Asthma
Drug: Glycopyrronium bromide 25ug
Drug: Glycopyrronium bromide 12.5ug

Phase 2

Novartis
Novartis

London, United Kingdom and 19 other locations

Locations recently updated

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Other: Placebo
Biological: Tezepelumab

Phase 3

AstraZeneca
AstraZeneca

London, United Kingdom and 97 other locations

BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...

Enrolling
Asthma
Drug: AZD4604
Other: Placebo

Phase 2

AstraZeneca
AstraZeneca

London, United Kingdom and 132 other locations

and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...

Enrolling
Asthma
Drug: Placebo
Drug: Atuliflapon

Phase 2

AstraZeneca
AstraZeneca

London, United Kingdom and 350 other locations

with amlitelimab in adult participants with moderate-to-severe asthma.Study details include:The study duration (per participant) will be up ...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Amlitelimab

Phase 2

Sanofi
Sanofi

London, London, City Of, United Kingdom and 122 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems